chr2-240788191-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP2PP5
The NM_001244008.2(KIF1A):c.223C>T(p.Arg75Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000626 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R75Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001244008.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KIF1A | NM_001244008.2 | c.223C>T | p.Arg75Trp | missense_variant | 4/49 | ENST00000498729.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KIF1A | ENST00000498729.9 | c.223C>T | p.Arg75Trp | missense_variant | 4/49 | 5 | NM_001244008.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000643 AC: 16AN: 248744Hom.: 0 AF XY: 0.0000888 AC XY: 12AN XY: 135104
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461530Hom.: 0 Cov.: 35 AF XY: 0.0000619 AC XY: 45AN XY: 727060
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74336
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2023 | Reported previously in the heterozygous state and co-occurring with a homozygous variant in the PTRH2 gene in a patient with severe axonal involvement and features of infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD); however, segregation information was not provided (Charles Bronson et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27124789, 26125038, 21376300, 21820098, 33717719, 33753861, Isa 2022) - |
Likely pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 28, 2023 | The KIF1A c.223C>T; p.Arg75Trp variant (rs778224699) is reported in an individual with ataxia, dystonia, spasticity and/or myotonia (Abouelhoda 2016) and two individuals with spastic paraplegia (Mereaux 2022), but has also been described in an individual with an alternative molecular explanation for disease (Charles Bronson 2021). This variant is reported in ClinVar (Variation ID: 191158) and is found in the general population with an overall allele frequency of 0.006% (17/280,134 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.653). Due to limited information, the clinical significance of the p.Arg75Trp variant is uncertain at this time. References: Abouelhoda et al. Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden. Genet Med. 2016 Dec;18(12):1244-1249. PMID: 27124789. Charles Bronson S et al. A Novel Synergistic Association of Variants in PTRH2 and KIF1A Relates to a Syndrome of Hereditary Axonopathy, Outer Hair Cell Dysfunction, Intellectual Disability, Pancreatic Lipomatosis, Diabetes, Cerebellar Atrophy, and Vertebral Artery Hypoplasia. Cureus. 2021 Feb 6;13(2):e13174. PMID: 33717719. Mereaux JL et al. Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia. Brain. 2022 Apr 29;145(3):1029-1037. PMID: 34983064. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 13, 2022 | - - |
Intellectual disability, autosomal dominant 9 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 18, 2017 | - - |
Hereditary spastic paraplegia 30 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Paris Brain Institute, Inserm - ICM | - | - - |
KIF1A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 26, 2024 | The KIF1A c.223C>T variant is predicted to result in the amino acid substitution p.Arg75Trp. This variant was reported in a patient presenting with global developmental delay, intellectual disability, weakness of upper and lower limbs, and diabetes who also carried a loss of function variant in PTRH2 (Charles Bronson. 2021. PubMed ID: 33717719). It's also been seen in patients with autism and hereditary spastic paraplegia (Chen. 2021. PubMed ID: 33753861, Méreaux. 2022. PubMed ID: 34983064).However, Additional information supporting the KIF1A c.223C>T variant's pathogenicity were not provided. This variant is reported in 0.016% of alleles in individuals of European (Finnish) descent in gnomAD. Of note, this variant has been observed in >100 heterozygotes in gnomad v4 (https://gnomad.broadinstitute.org/variant/2-240788191-G-A?dataset=gnomad_r4). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 75 of the KIF1A protein (p.Arg75Trp). This variant is present in population databases (rs778224699, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of KIF1A-related conditions (PMID: 27124789, 33717719, 33753861). ClinVar contains an entry for this variant (Variation ID: 191158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KIF1A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at